Achieving more accurate and convincing MSLN CAR cell-mediated targeting is the primary goal of several research groups but requires the tackling of various challenges such as production, infiltration into solid tumors, and overcoming the immunosuppressive effects of the tumor microenvironment [146,147]. This evidence concerns the gene MSLN and neoplasm.